Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients
Natsumi Matsumoto, Yutaro Kubota, Hiroo Ishida, Masae Sekido, Ryotaro Ohkuma, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Takuya Tsunoda, Toshikazu Ikusue, Kouji Kobayashi, Atsushi Hisamatsu, Hirokazu Toshima, Ken Shimada, Ken‐ichi Fujita
Topics & Concepts
CapecitabineOxaliplatinPharmacokineticsToxicityProdrugPharmacologyColorectal cancerMedicineFluorouracilInternal medicineOncologyChemotherapyCancerColorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyBerberine and alkaloids research